Alan Graff - Concepedia

Author

Alan Graff

University of Fort Lauderdale

Also Known As

A C DE GRAFF, A Graff, A. C. De Graff, A. C. de Graff, A. Graff, Alan Graff

Publications

613

Citations

H-Index

Concepts

All Affiliations

University of Fort Lauderdale Rush University Medical Center University of Miami Presbyterian St. Luke's Medical Center Orange County Research Center

About

Alan Graff is an author at University of Fort Lauderdale specializing in medicine, hypertension, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	367
2	Pharmacology	3	3	318
3	Hypertension	3	3	318
4	Metabolism	1	1	49
5	Nutrition	1	1	49

Alan Graff

Publications

588

Citations

H-Index

Page 1

	Year	Citations
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril HR Black, Alan Graff, D Shute, Journal of Human Hypertension HypertensionCardiovascular DiseaseAntihypertensive TherapyPharmacologyCardiovascular Pharmacology	1997	120
Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy JR Benz, HR Black, Alan Graff, Journal of Human Hypertension HypertensionMedicineAntihypertensive TherapyMultiple DosePharmacotherapy	1998	116
Comparison of Amlodipine and Benazepril Monotherapy to Amlodipine Plus Benazepril In Patients with Systemic Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study William H. Frishman, C. Venkata S. Ram, F. Gilbert McMahon, The Journal of Clinical Pharmacology	1995	92
A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide Willa A. Hsueh, Shawna D. Nesbitt, Thomas J. Littlejohn, Journal of Clinical Hypertension	2011	83
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: A double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults James L. Pool, Robert Glazer, Myron H. Weinberger, Clinical Therapeutics Hypertensive AdultsNon-pharmacological InterventionHypertensionMedicineAntihypertensive Therapy	2007	82
The utilization of blood sugar and lactate by the heart‐lung preparation C. Lovatt Evans, Alan Graff, Takao Kosaka, The Journal of Physiology NutritionPhysiologyPulmonary PhysiologyRespiration (Physiology)Metabolism	1933	49
The Use of a Single‐Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo‐Controlled, Multicenter Study Joel M. Neutel, William H. Bestermann, Eric M. Dyess, Journal of Clinical Hypertension	2009	46

Page 1